Cognition Therapeutics Inc (CGTX)
2.55
-0.05
(-1.92%)
USD |
NASDAQ |
May 24, 16:00
2.54
-0.01
(-0.39%)
After-Hours: 20:00
Cognition Therapeutics Total Liabilities (Quarterly): 9.991M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 9.991M |
| December 31, 2023 | 10.69M |
| September 30, 2023 | 9.846M |
| June 30, 2023 | 9.574M |
| March 31, 2023 | 9.88M |
| December 31, 2022 | 10.18M |
| September 30, 2022 | 14.24M |
| Date | Value |
|---|---|
| June 30, 2022 | 8.913M |
| March 31, 2022 | 9.956M |
| December 31, 2021 | 7.864M |
| September 30, 2021 | 100.11M |
| June 30, 2021 | 100.97M |
| March 31, 2021 | 84.37M |
| December 31, 2020 | 75.30M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.864M
Minimum
Dec 2021
100.97M
Maximum
Jun 2021
32.99M
Average
10.08M
Median
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
| Theriva Biologics Inc | 14.61M |
| Oragenics Inc | 0.9087M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 38.85M |
| Shareholders Equity (Quarterly) | 28.86M |